Description
The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Naloxone | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Naloxone | HTML | Open resource |